EXPO - Exponent, Inc. Stock Analysis | Stock Taper
Logo
Exponent, Inc.

EXPO

Exponent, Inc. NASDAQ
$59.48 2.01% (+1.17)

Market Cap $2.88 B
52w High $81.95
52w Low $51.91
Dividend Yield 1.64%
Frequency Quarterly
P/E 27.79
Volume 499.80K
Outstanding Shares 48.51M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $166.3M $6.2M $29.57M 17.78% $0.59 $43.89M
Q4-2025 $147.43M $6.71M $24.76M 16.8% $0.49 $36.64M
Q3-2025 $147.12M $7.65M $28.04M 19.06% $0.55 $41.15M
Q2-2025 $141.96M $6.14M $26.55M 18.7% $0.52 $34.32M
Q1-2025 $145.51M $93M $26.65M 18.32% $0.52 $40.25M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $118.55M $687.38M $349.04M $338.34M
Q4-2025 $221.93M $808.62M $418.27M $390.34M
Q3-2025 $207.38M $761.45M $358.59M $402.86M
Q2-2025 $231.8M $759.43M $331.65M $427.78M
Q1-2025 $245.11M $763.24M $321.83M $441.41M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $29.57M $-975K $-2.45M $-99.68M $-103.38M $-3.43M
Q4-2025 $24.76M $55.58M $-2.69M $-38.4M $14.55M $52.9M
Q3-2025 $28.04M $32.65M $-2.67M $-54.51M $-24.42M $29.98M
Q2-2025 $26.55M $36.22M $-2.27M $-47.47M $-13.31M $33.95M
Q1-2025 $26.65M $7.27M $-1.75M $-20.05M $-13.79M $5.52M

Revenue by Products

Product Q1-2025Q2-2025Q4-2025Q1-2026
Engineering And Other Scientific
Engineering And Other Scientific
$120.00M $120.00M $250.00M $140.00M
Environmental And Health
Environmental And Health
$20.00M $20.00M $40.00M $20.00M

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Exponent, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Exponent combines steady revenue growth with high and resilient profitability, supported by strong cash generation and low capital intensity. Its balance sheet is conservative, with historically more cash than debt and growing retained earnings. The company operates in a defensible niche at the intersection of engineering, science, regulation, and litigation, where reputation, multidisciplinary expertise, and specialized testing facilities create meaningful barriers to entry. Consistent free cash flow has enabled rising dividends and shareholder returns without compromising core operations.

! Risks

Key risks include a gradual tightening of liquidity as cash cushions shrink and leverage ticks up from very low levels, even if overall debt remains manageable. Margins at the project level have shown some pressure from rising delivery costs, and the absence of explicit R&D spending could become a concern if it signals underinvestment in new capabilities. The business is heavily dependent on the recruitment and retention of highly skilled experts, making talent a structural vulnerability. Demand can also fluctuate with litigation trends, regulatory shifts, and client budgets for risk and safety‑related consulting. Finally, any damage to the firm’s hard‑won reputation for objectivity and technical rigor would be difficult to repair.

Outlook

The overall outlook appears favorable but not without caveats. Exponent is well placed to benefit from growing technological complexity, stricter regulation, and heightened focus on safety and reliability in areas like electrification, AI, digital health, and advanced energy systems. Its financial profile provides resilience and flexibility to invest in people and capabilities, even as the balance sheet becomes slightly less conservative. Future performance will hinge on maintaining strong margins, managing liquidity prudently, and continuing to deepen its expertise in emerging technologies. While past trends point to a stable, high‑quality business, outcomes will still depend on external factors such as regulatory environments, litigation volumes, and the pace of technological change in its end markets.